Faculty

The WSAAI has assembled a world-class faculty for the 2019 Annual Meeting.  They include:

Noam Cohen, MD, PhD

Noam Cohen, MD, PhD

Session Topics
  • Sinonasal Innate Immunity and the Microbiome
  • Post- Surgical Management of CRS: New Technologies
Richard Gallo, MD, PhD

Richard Gallo, MD, PhD

Session Topics
  • Host Microbe Interactions in the Pathogenesis of Atopic Dermatitis
  • Bacteriotherapy of Atopic Dermatitis. Fallacies, Facts and the Future
Catherine Lozupone, PhD

Catherine Lozupone, PhD

Session Topics
  • Overview of the Microbiome and its Impact on Inflammatory Disease
  • The Intersection of Microbiome, Diet and Inflammatory Disease
Jordan Orange, MD, PhD

Jordan Orange, MD, PhD

Session Topics
  • Personalized Approach to Primary Immunodeficiency
  • Update on Immunoglobulin Therapies and Personalization of Application
David Peden, MD

David Peden, MD

Session Topics
  • Indoor Biomass and Wildfire Smoke Exposure and Human Health
  • The Effect of Air Pollutants on Asthma, Allergic and Immunologic Disease
Michael Schatz, MD

Michael Schatz, MD

Session Topics
  • Asthma and Drug Allergy
  • The Harold S. Nelson, MD Lecture: Asthma and Allergic Diseases during Pregnancy
Scott Sicherer, MD

Scott Sicherer, MD

Session Topics
  • Mastering the Food Allergy Diagnosis
  • Food Allergy and Anaphylaxis
Donata Vercelli, MD

Donata Vercelli, MD

Session Topics
  • Can Microbes Protect from Asthma? Studies with Amish and Hutterite Gut Microbiota
  • Epigenetics of Asthma: Can We Predict Childhood Disease at Birth or Even Earlier?
Katharine Woessner, MD

Katharine Woessner, MD

Session Topics
  • What Have We Learned from Aspirin Desensitization in AERD: How Can the Methods be Improved?
  • Drug Allergy/ Hypersensitivity Management:  An Examination of Drug Allergies likely to be Encountered by the Practicing Allergist
Bruce Zuraw, MD

Bruce Zuraw, MD

Session Topics
  • Update on HAE with Normal C1 Inhibitor – Classification, Diagnosis and Management
  • The Ever-Changing Therapeutic Landscape for HAE due to C1 Inhibitor Deficiency